Abstract: As an effective therapy for proliferative skin and eye diseases such as psoriasis and proliferative diabetic retinopathy, this invention provides ribozymes and ribozyme delivery systems which cleave RNA encoding cytokines involved in inflammation, matrix metalloproteinases, a cyclin, a cell-cycle dependent kinase, a growth factor, or a reductase.
Abstract: The invention provides triamine derivative melanocortin receptor ligands of the formula:
wherein R1 to R8 and n have the meanings provided herein. The invention further provides methods of using the ligands to alter or regulate the activity of a melanocortin receptor.
Type:
Grant
Filed:
August 4, 2000
Date of Patent:
July 27, 2004
Assignee:
Lion Bioscience AG
Inventors:
Karen J. Watson-Straughan, Timothy C. Gahman, Ming Qi, Christa Hamashin, James E. Macdonald, Michael J. Green, Kevin R. Holme, Michael C. Griffith
Abstract: The present invention relates to novel pyridine carboxamide or sulfonamide derivative compounds of the following formula:
wherein R1 to R6 have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing pyridine carboxamide or sulfonamide derivative compounds.
Abstract: The present invention relates to novel tetracyclic benzimidazole derivative compounds of the following formula:
wherein R1 to R10 have the meanings described in here.
The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing tetracyclic benzimidazole derivative compounds.
Abstract: The present invention relates to novel 2-aminopyridine derivative compounds of the following formula:
wherein R1 to R5 have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing 2-aminopyridine derivative compounds.
Type:
Grant
Filed:
September 29, 1999
Date of Patent:
October 1, 2002
Assignee:
Lion Bioscience AG
Inventors:
Behrouz Forood, Brenton T. Flatt, Christophe Chassaing, Alan K. Katritzky
Abstract: This invention provides ribozymes useful to treat or prevent Hepatitis C Virus (“HCV”) infection or disease in an organism or subject, as well as methods of treating an HCV infection or disease. Reagents such as vectors, host cells, DNA molecules coding for these ribozymes usefull in methods of treatment and prevention of HCV infection or disease are also provided.
Type:
Grant
Filed:
November 1, 1999
Date of Patent:
October 1, 2002
Assignee:
Immusol, Inc.
Inventors:
Jack R. Barber, Peter J. Welch, Richard Tritz, SoonPin Yei, Mang Yu
Abstract: The present invention relates to novel dihydroisoquinolinone (DHQ) derivative compounds of the following formula:
wherein R1 to R7, X, Y, Z, b, c and d have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing DHQ derivative compounds.
Type:
Grant
Filed:
August 19, 1999
Date of Patent:
September 17, 2002
Assignee:
Lion Bioscience AG
Inventors:
Kianoush Motesharei, Michal Lebl, Viktor Krchnak, Yidong Ni
Abstract: The present invention provides the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinoline derivatives as well as novel libraries comprised of such compounds.
Abstract: The present invention relates to novel 4-substituted quinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds:
wherein R1, R2, R3, R4, R5, R6, R7, R9, and Y, have the meanings provided.
Type:
Grant
Filed:
August 16, 1999
Date of Patent:
May 14, 2002
Assignee:
Lion bioscience AG
Inventors:
Thomas K. Hayes, Behrouz Forood, John S. Kiely
Abstract: The present invention relates to novel triazole compounds of the following formula:
wherein R1 to R5 have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing triazole compounds.
Type:
Grant
Filed:
June 29, 1999
Date of Patent:
March 26, 2002
Assignee:
Lion Bioscience AG
Inventors:
Ming Qi, R. Normand Hebert, Alan R. Katritzky
Abstract: The invention provides a rapid approach for combinatorial synthesis and screening of combinatorial libraries of bicyclic guanidine compounds. The present invention further provides the compounds made by the combinatorial synthesis and individually as well as methods of using the same.
Type:
Grant
Filed:
February 3, 1998
Date of Patent:
March 19, 2002
Assignee:
Lion Bioscience AG
Inventors:
John M. Ostresh, Jean-Philippe Meyer, Colette T. Dooley, Sylvie E. Blondelle, Christa C. Schoner, Richard A. Houghten
Abstract: The present invention relates to novel 4-substituted quinoline compounds of the following formula, libraries containing such compounds, and to the generation of such combinatorial libraries composed of such compounds:
wherein R1, R2, R3, R4, R5, R6, R7, R9, and Y, have the meanings provided.
Type:
Grant
Filed:
February 3, 1998
Date of Patent:
July 17, 2001
Assignee:
Trega Biosciences, Inc.
Inventors:
Thomas K. Hayes, Behrouz Forood, John S. Kiely